Medical specialists from France tagged as investigators in clinical trials studying Cystic Fibrosis

Total 90 results

Alain Haloun, MD
Seen in:
- Nantes, Centre Hospitalier Universitaire de Nantes
Trials:
- NCT02888730 (Sub-Investigator)
Conditions:
Andre Coste, MD PhD
Seen in:
- Creteil, Centre Hospitalier Intercommunal de Créteil
Trials:
- NCT02888730 (Sub-Investigator)
Conditions:
Andre Labbe, MD PhD
Seen in:
- Clermont Ferrand, Centre Hospitalier Universitaire de Clermont Ferrand
Trials:
- NCT02888730 (Sub-Investigator)
Conditions:
Annabelle Payet-Charneau, MD
Seen in:
- Saint-Pierre, CHR Sud Réunion
Trials:
- NCT03312075 (Sub-Investigator)
Conditions:
- Cystic Fibrosis
Anne Prévotat, MD
Seen in:
- Lille, CHRU de Lille
- Lille, Hôpital Calmette, CHRU
- Lille, Hôpital Calmette,CHU
Trials:
- NCT02994017 (Principal Investigator)
- NCT03670472 (Principal Investigator)
- NCT03565692 (Sub-Investigator)
Conditions:
- Cystic Fibrosis
Audrey BARZIC, Dr
Seen in:
- Roscoff, Centre de Perharidy
Trials:
- NCT03947957 (Principal Investigator)
Conditions:
- Cystic Fibrosis
Audrey HERZOG
Seen in:
- Strasbourg, Hopitaux Universitaire de Strasbourg
Trials:
- NCT04847882 (Principal Investigator)
Conditions:
- Sleep Disorder;
- Cystic Fibrosis
Bérengère Coltey, MD
Seen in:
- Marseille, Marseille University Hospital - Pneumology department
Trials:
- NCT04096664 (Principal Investigator)
Conditions:
- Pulmonary Cystic Fibrosis
Bruno Housset, MD PhD
Seen in:
- Creteil, Centre Hospitalier Intercommunal de Créteil
Trials:
- NCT02888730 (Sub-Investigator)
Conditions:
Bruno Ravoninjatovo, MD
Seen in:
- Reims, CHU Reims
Trials:
- NCT04096664 (Sub-Investigator)
Conditions:
- Pulmonary Cystic Fibrosis
carole Bailly, MD
Seen in:
- Nice, Centre Hosiptalier de Nice
Trials:
- NCT02888730 (Sub-Investigator)
Conditions:
Carole Piccini Bailly, MD
Seen in:
- Nice, Nice University-Affiliated Hospital : Pneumo-pediatric department
Trials:
- NCT04096664 (Principal Investigator)
Conditions:
- Pulmonary Cystic Fibrosis
Catherine Llerena, MD
Seen in:
- Grenoble, Centre Hospitalier Universitaire Grenoble Alpes
Trials:
- NCT03565692 (Principal Investigator)
Conditions:
- Cystic Fibrosis
Cathy Llerena, MD
Seen in:
- Grenoble, Grenoble University Hospital : pneumo-pediatric department
Trials:
- NCT04096664 (Principal Investigator)
Conditions:
- Pulmonary Cystic Fibrosis
Claire Poulet, MD
Seen in:
- Amiens, CHU Amiens Picardie
- Picardie, Amiens, CHU Amiens Picardie
Trials:
- NCT04096664 (Sub-Investigator)
- NCT05813418 (Sub-Investigator)
Conditions:
Dominique Grenet, MD
Seen in:
- Suresnes, Hôpital Foch
Trials:
- NCT03565692 (Principal Investigator)
Conditions:
- Cystic Fibrosis
Elie Serrano, MD PhD
Seen in:
- Toulouse, Centre Hospitalier Universitaire de Toulouse
Trials:
- NCT02888730 (Sub-Investigator)
Conditions:
Eric DENEUVILLE, Dr
Seen in:
- Rennes, CHRU Rennes
Trials:
- NCT03947957 (Principal Investigator)
Conditions:
- Cystic Fibrosis
François Bremont, MD
Seen in:
- Toulouse, Centre Hospitalier Universitaire de Toulouse
Trials:
- NCT02888730 (Sub-Investigator)
Conditions:
Françoise Troussier, MD
Seen in:
- Angers, Chu Angers
Trials:
- NCT04096664 (Sub-Investigator)
Conditions:
- Pulmonary Cystic Fibrosis
Francosie TROUSSIER, Dr
Seen in:
- Angers, CHRU Angers
Trials:
- NCT03947957 (Principal Investigator)
Conditions:
- Cystic Fibrosis
Gabriel Bellon, Pr
Seen in:
- Bron, Centre de ressources et de compétences pour la mucovisidose, enfants
- Lyon, Centre de Ressource et de Compétence Mucoviscidose Pédiatrique Centre de Référence Mucoviscidose
Trials:
- NCT01337219 (Principal Investigator)
- NCT01288170 (Principal Investigator)
Conditions:
- Cystic Fibrosis
Géraldine Labouret, MD
Seen in:
- Toulouse, Centre Hospitalier Universitaire de Toulouse
Trials:
- NCT02888730 (Sub-Investigator)
Conditions:
Harriet Corvol, MD,PhD
Seen in:
- Paris, Assistance Publique Hopitaux De Paris
Trials:
- NCT03565692 (Principal Investigator)
Conditions:
- Cystic Fibrosis
Isabelle Durieu
Seen in:
- Lyon, Hospices Civils de Lyon
- Pierre-Bénite, Centre de ressources et de compétences pour la mucovisidose, adultes
Trials:
- NCT05099939 (Principal Investigator)
- NCT01288170 (Sub-Investigator)
Conditions:
- Cystic Fibrosis
Isabelle Sermet-Gaudelus, MD,PhD
Seen in:
- Paris, Assistance Publique Hopitaux De Paris
Trials:
- NCT03565692 (Sub-Investigator)
Conditions:
- Cystic Fibrosis
Iulia IOAN, MD
Seen in:
- Nancy, Service de pédiatrie, CHRU de Nancy - Hôpitaux de Brabois
Trials:
- NCT06370962 (Principal Investigator)
Conditions:
- Cystic Fibrosis

Clinical Trials on Cystic Fibrosis

Hospital de Clinicas de Porto Alegre

Unknown

Program Of Exercises During The Hospitalization Of Children And Adolescents With Cystic Fibrosis

Cystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children | Cystic Fibrosis With Exacerbation

Brazil
University of Colorado, Denver
Cystic Fibrosis Foundation

Terminated

Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management

Cystic Fibrosis-related Diabetes | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children

United States
Royal College of Surgeons, Ireland
The Hospital for Sick Children; Imperial College London; Erasmus Medical Center; University College Dublin and other collaborators

Active, not recruiting

Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER) (RECOVER)

Cystic Fibrosis | Adherence, Medication | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in Children | Cystic Fibrosis Liver Disease

United Kingdom, Ireland
Herlev and Gentofte Hospital
Copenhagen University Hospital, Denmark

Active, not recruiting

Cardiac Structure and Function in Patients With Cystic Fibrosis

Myocardial Infarction | Heart Diseases | Heart Failure | Stroke | Cystic Fibrosis | Heart Failure, Diastolic | Heart Failure, Systolic | Left Ventricular Dysfunction | Cystic Fibrosis-related Diabetes | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of Pancreas | Cystic Fibrosis, Pulmonary | Cystic...

Denmark
The Hospital for Sick Children
Canadian Cystic Fibrosis Foundation

Active, not recruiting

Intestinal Inflammation in CF Patients

Cystic Fibrosis | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in Children

Canada
Arrowhead Pharmaceuticals

Terminated

Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis

Cystic Fibrosis, Pulmonary

Australia, New Zealand
AzurRx SAS

Completed

Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs

Cystic Fibrosis | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of Pancreas

Turkey, Hungary
Dartmouth-Hitchcock Medical Center
Trustees of Dartmouth College

Withdrawn

Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis

Cystic Fibrosis-related Diabetes | Cystic Fibrosis Liver Disease | CF - Cystic Fibrosis

United States
University Hospital, Bordeaux

Completed

Estimated Impact of Fungal Colonization in Cystic Fibrosis From Secondary Exploitation of MucoFong Database. (MucoFong2)

Cystic Fibrosis Lung

France
Mack Biotech, Corp.

Completed

Airway Clearance System (K031876) Phase IV Device Efficacy

Cystic Fibrosis, Pulmonary

United States

Medical specialists from France tagged as investigators in clinical trials studying Cystic Fibrosis

Clinical Trials on Cystic Fibrosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations